Overview

A Study to Investigate the Effect of PH-797804 on QTc Interval

Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the effect of PH-797804 following dosing of a 24 mg oral tablet on the QTc interval
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer
Treatments:
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination